Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ewing's tumor].

M Taylor1, M Guillon, V Champion

  • 1Service d'oncologie pédiatrique, institut Gustave-Roussy, rue Camille-Desmoulins, 94805 Villejuif, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|July 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Joint replacement risk is markedly increased in alkaptonuria (AKU) in those with prior arthroplasty.

Molecular genetics and metabolism reports·2024
Same author

Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria.

Scientific reports·2022
Same author

Digital contact-tracing in France: uptake by COVID-19 risk factor and by exposure risk.

Journal of public health (Oxford, England)·2021
Same author

Factors associated with COVID-19 vaccination intentions and attitudes in France.

Public health·2021
Same author

Attitudes and opinions on quarantine and support for a contact-tracing application in France during the COVID-19 outbreak.

Public health·2020
Same author

Management of 35 critically ill hyperammonemic neonates: Role of early administration of metabolite scavengers and continuous hemodialysis.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2020
Same journal

Family experiences of paediatric palliative care during hospital-at-home: a systematic review.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Knowledge of maternity caregivers on vaccination BCG recommendations and circuits.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

"CRANIOQUALITY study: Quality of life in children with non-syndromic craniosynostosis after surgery".

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Chronological evolution of brain imaging of hemiconvulsion-hemiplegia-epilepsy from 5 cases in Mayotte island.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Point-of-care capillary blood ketone testing to predict the need for intravenous or nasogastric tube rehydration in children with acute gastroenteritis.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same journal

Transition practices of patients with inflammatory bowel disease from pediatric to adult healthcare systems. Results from a national survey.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
See all related articles

Ewing's tumor (ET) is a rare bone cancer diagnosed by a specific genetic marker. Advances in chemotherapy and supportive care have significantly improved outcomes and quality of life for patients.

Area of Science:

  • Oncology
  • Genetics
  • Pediatric Oncology

Context:

  • Ewing's tumor (ET) is a rare malignant bone tumor primarily affecting children and young adults.
  • ET characteristically involves the central axis bones and soft tissue infiltration.
  • A unique genetic translocation, EWS-FLI-1 fusion, is a hallmark of ET, classifying it among neuroectodermal tumors.

Purpose:

  • To review the diagnostic and therapeutic advancements in Ewing's tumor management.
  • To highlight the role of genetic alterations in ET diagnosis and prognosis.
  • To discuss the evolution of treatment strategies and their impact on patient outcomes.

Summary:

  • ET is diagnosed via a specific genetic translocation (EWS-FLI-1 fusion), serving as a diagnostic and prognostic marker.

Related Experiment Videos

  • Multiagent chemotherapy combined with local treatments (surgery/radiation) has improved outcomes for ET patients.
  • Intensified therapies have led to cures in some metastatic cases, though side effects require careful management.

    • Impact:

    • Improved understanding of ET pathogenesis through genetic discovery.
    • Enhanced patient survival rates and quality of life due to advanced treatment protocols.
    • ET serves as a model for progress in cancer research, diagnostics, and therapeutics over the past century.